benefits of glp-1 Can one drug do it all? Reviewing the expanding clinical universe agonists Glucagon-like peptide 1 receptor agonists:
Description
Zepbound is approved for weight loss in adults with obesity or overweight and at least one weight-related medical condition
Demand for these medications has transformed Novo Nordisk and its rival Eli Lilly $LLY (LLY), the producer of competing drugs Mounjaro and Zepbound, into the largest pharma companies in the world
[DOI] [PubMed] [Google Scholar] 147
Data are available with approval through the individual constituent entities controlling access to the data
Nature (Scientific Reports)
